N.CER Overview

  • Year Founded
  • 2019

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Series A

  • Investors
  • 11

N.CER General Information

Description

Developer of diagnostic systems designed to detect dementia. The company develops a medical device using olfactory response and near-infrared spectroscopy that screens out early dementia that is difficult to distinguish with the existing questionnaire or imaging method, enabling doctors to diagnose early dementia based on changes in brain blood flow during sensory stimulation.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Room 316, E3, 123
  • Cheomdangwagi-ro, Buk-gu
  • Gwangju
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Vertical(s)
Corporate Office
  • Room 316, E3, 123
  • Cheomdangwagi-ro, Buk-gu
  • Gwangju
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

N.CER Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 02-Apr-2026 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Early Stage VC (Series A) 22-Aug-2021 Completed Generating Revenue
2. Accelerator/Incubator 01-Feb-2020 $430K Completed Generating Revenue
1. Seed Round 15-Jan-2020 $430K $430K Completed Generating Revenue
To view N.CER’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

N.CER Patents

N.CER Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2025042241-A1 Fragrance recommendation device and system Inactive 24-Aug-2023
WO-2023017941-A1 System for comprehensive analysis of dementia or degenerative brain disease Inactive 11-Aug-2021
WO-2023017940-A1 Dementia examination device mounted for dementia level classification, and method for classifying dementia levels using same Inactive 10-Aug-2021
WO-2022182093-A1 Apparatus and method for analyzing exercise amount and exercise intensity applied to muscles Inactive 26-Feb-2021
WO-2022108297-A1 Device for alleviating dementia symptoms Inactive 19-Nov-2020 A61M21/00
To view N.CER’s complete patent history, request access »

N.CER Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

N.CER Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
Colopl Next Corporate Venture Capital Minority
Cosine Investment Venture Capital Minority
DT & Investment Corporate Venture Capital Minority
Enlight Ventures Venture Capital Minority
G1 (South Korea) Corporation Minority
You’re viewing 5 of 11 investors. Get the full list »

N.CER FAQs

  • When was N.CER founded?

    N.CER was founded in 2019.

  • Where is N.CER headquartered?

    N.CER is headquartered in Gwangju, South Korea.

  • What is the size of N.CER?

    N.CER has 6 total employees.

  • What industry is N.CER in?

    N.CER’s primary industry is Diagnostic Equipment.

  • Is N.CER a private or public company?

    N.CER is a Private company.

  • What is N.CER’s current revenue?

    The current revenue for N.CER is .

  • How much funding has N.CER raised over time?

    N.CER has raised $2.42M.

  • Who are N.CER’s investors?

    Colopl Next, Cosine Investment, DT & Investment, Enlight Ventures, and G1 (South Korea) are 5 of 11 investors who have invested in N.CER.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process